Barton Shane insider trades
Barton Shane has filed 10 Form 4s with the SEC that we hold, for BioAge Labs, Inc. (BIOA) (Principal Accounting Officer) and Precision Biosciences INC (DTIL) (VP & Corporate Controller). Across all of them we count 1 purchase worth $47.4K and 2 sales worth $1.6M reported on Form 4. In the last 12 months: 0 purchases ($0) and 2 sales ($1.6M). The largest single trade was a sale of 42,350 shares of BioAge Labs, Inc. worth $1.1M, dated 2026-06-29. The first filing on our record is dated 2022-03-07 and the latest 2026-07-01.
BioAge Labs, Inc. (BIOA)
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2024-09-27 | P, purchase reported on Form 4 | 2,632 | $47.4K | 2025-03-10 |
| 2026-06-29 | S, sale reported on Form 4 | 42,350 | $1.1M | 2026-07-01 |
| 2026-06-30 | S, sale reported on Form 4 | 20,216 | $509.2K | 2026-07-01 |
Precision Biosciences INC (DTIL)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Counted from the Form 4 filings this reporting owner (SEC CIK 1836297) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
Source: U.S. Securities and Exchange Commission (EDGAR) and other official
government data · Updated 2026-10-12 ·
For informational purposes only, not investment advice.
Privacy · Terms